Dooley KE, Hendricks B, Gupte N, Barnes G, et al. Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results. Am J Respir Crit Care Med 2022 Dec 1. doi: 10.1164/rccm.202208-1475.
PMID: 36455068